Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03655-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Itsuki Anzai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT), MEXT | Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
Although the global crisis caused by the coronavirus disease 2019 (COVID-19) pandemic is over, the global epidemic of the disease continues. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of COVID-19, initiates infection via the binding of the receptor-binding domain (RBD) of its spike protein to the human angiotensin-converting enzyme II (ACE2) receptor, and this interaction has been the primary target for the development of COVID-19 therapeutics. Here, we identified neutralizing antibodies against SARS-CoV-2 by screening mouse monoclonal antibodies and characterized an antibody, CSW1-1805, that targets a narrow region at the RBD ridge of the spike protein. CSW1-1805 neutralized several variants in vitro and completely protected mice from SARS-CoV-2 infection. Cryo-EM and biochemical analyses revealed that this antibody recognizes the loop region adjacent to the ACE2-binding interface with the RBD in both a receptor-inaccessible “down” state and a receptor-accessible “up” state and could stabilize the RBD conformation in the up-state. CSW1-1805 also showed different binding orientations and complementarity determining region properties compared to other RBD ridge-targeting antibodies with similar binding epitopes. It is important to continuously characterize neutralizing antibodies to address new variants that continue to emerge. Our characterization of this antibody that recognizes the RBD ridge of the spike protein will aid in the development of future neutralizing antibodies. IMPORTANCE SARS-CoV-2 cell entry is initiated by the interaction of the viral spike protein with the host cell receptor. Therefore, mechanistic findings regarding receptor recognition by the spike protein help uncover the molecular mechanism of SARS-CoV-2 infection and guide neutralizing antibody development. Here, we characterized a SARS-CoV-2 neutralizing antibody that recognizes an epitope, a loop region adjacent to the receptor-binding interface, that may be involved in the conformational transition of the receptor-binding domain (RBD) of the spike protein from a receptor-inaccessible “down” state into a receptor-accessible “up” state, and also stabilizes the RBD in the up-state. Our mechanistic findings provide new insights into SARS-CoV-2 receptor recognition and guidance for neutralizing antibody development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
- Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, Japan.
- Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
- JEOL YOKOGUSHI Research Alliance Laboratories, Osaka University, Suita, Osaka, Japan.
- Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
- Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Itsuki Anzai, Tokiko Watanabe, Yoshiharu Matsuura
Förderung
- Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Japan Agency for Medical Research and Development (AMED)
- MEXT | Japan Science and Technology Agency (JST)
Zitieren
APA
Anzai, I., Fujita, J., Ono, C., Kosaka, Y., Miyamoto, Y., Shichinohe, S., Takada, K., Torii, S., Taguwa, S., Suzuki, K., Makino, F., Kajita, T., Inoue, T., Namba, K., Watanabe, T., & Matsuura, Y. (2024). Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03655-23
Vancouver
Anzai I, Fujita J, Ono C, Kosaka Y, Miyamoto Y, Shichinohe S, et al. Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03655-23
BibTeX
@article{Anzai2024,
author = {Anzai, Itsuki and Fujita, Junso and Ono, Chikako and Kosaka, Yoichiro and Miyamoto, Yuki and Shichinohe, Shintaro and Takada, Kosuke and Torii, Shiho and Taguwa, Shuhei and Suzuki, Koichiro and Makino, Fumiaki and Kajita, Tadahiro and Inoue, Tsuyoshi and Namba, Keiichi and Watanabe, Tokiko and Matsuura, Yoshiharu},
title = {Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03655-23}
}
EUVIMED